BRIEF-Reata Pharmaceuticals secures $35 mln term loan facility
April 3 Reata Pharmaceuticals Inc
* Reata Pharmaceuticals, Inc. secures $35 million term loan facility
* Reata Pharmaceuticals Inc says entered into a $35 million loan and security agreement with Oxford Finance Llc and Silicon Valley Bank
* Reata Pharma - proceeds will be utilized primarily to support multiple phase 2, 3 clinical trial programs for bardoxolone methyl and omavaloxolone Source text for Eikon: Further company coverage: